WallStreetZenWallStreetZen

NASDAQ: GDTC
Cytomed Therapeutics Ltd Stock Forecast, Predictions & Price Target

Analyst price target for GDTC

Based on 1 analyst offering 12 month price targets for Cytomed Therapeutics Ltd.
Min Forecast
$5.00+138.66%
Avg Forecast
$5.00+138.66%
Max Forecast
$5.00+138.66%

Should I buy or sell GDTC stock?

Based on 1 analyst offering ratings for Cytomed Therapeutics Ltd.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GDTC stock forecasts and price targets.

GDTC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-06-11

1 of 1

GDTC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GDTC$2.10$5.00+138.66%Buy
ALGS$7.50$75.00+900.00%Buy
MRKR$2.78$11.00+295.68%Strong Buy
LSTA$2.99$15.00+401.67%Buy
UBX$1.49$8.00+436.91%Buy

Cytomed Therapeutics Stock Forecast FAQ

Is Cytomed Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: GDTC) stock is to Buy GDTC stock.

Out of 1 analyst, 0 (0%) are recommending GDTC as a Strong Buy, 1 (100%) are recommending GDTC as a Buy, 0 (0%) are recommending GDTC as a Hold, 0 (0%) are recommending GDTC as a Sell, and 0 (0%) are recommending GDTC as a Strong Sell.

If you're new to stock investing, here's how to buy Cytomed Therapeutics stock.

What is GDTC's Price Target?

According to 1 Wall Street analyst that have issued a 1 year GDTC price target, the average GDTC price target is $5.00, with the highest GDTC stock price forecast at $5.00 and the lowest GDTC stock price forecast at $5.00.

The Wall Street analyst predicted that Cytomed Therapeutics's share price could reach $5.00 by Jun 11, 2025. The average Cytomed Therapeutics stock price prediction forecasts a potential upside of 138.66% from the current GDTC share price of $2.10.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.